secwatch.observer — SEC 8-K summary
======================================

Issuer:     Glucotrack, Inc. (GCTK)
CIK:        0001506983
Form:       8-K
Filed at:   2025-05-20T23:59:59+00:00
Accession:  0001641172-25-011610
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Glucotrack forms Patient Advisory Board to guide implantable CBGM development
-----------------------------------------------------------------------------

- Patient Advisory Board (PAB) formed with leading diabetes patient advocates and voices.
- Inaugural PAB meeting held on May 3, 2025; will convene regularly.
- PAB aims to keep patient insights at the forefront of long-term implantable CBGM development.
- CBGM is designed for up to 3 years of continuous blood glucose monitoring, no wearable component.
- CBGM is an Investigational Device limited by federal law to investigational use.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506983/000164117225011610/0001641172-25-011610-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506983/000164117225011610/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-011610

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer